Procurement teams protect assays by stopping lots when documentation fails basic traceability—before any lab exposure.
Failure 1: No lot identifier. A COA without a lot cannot be tied to a specific vial.
Failure 2: Name drift. COA naming that diverges from the vial label or catalog SKU is a mismatch event.
Failure 3: Missing method context. A purity number alone is not a reproducible analytical claim.
Failure 4: Stale or duplicated dates reused across unrelated lots.
Failure 5: Purity claims that ignore sequence complexity without supporting chromatogram detail.
Failure 6: No identity confirmation for novel or long sequences.
Failure 7: Broken third-party links or unverifiable task keys when a report is advertised.
Log rejection reasons and notify vendor channels listed on sulan-peptide.shop.
Use Janoshik verification as a second layer when a published third-party report is part of your vendor scorecard.
Track COA quality trends over time—price alone is a weak renewing criterion.
RUO compliance depends on documentation integrity; never skip review to protect a schedule.
Institutional auditors typically ask for a chain from sample ID to supplier COA PDF and quote email—build that link early.
International teams should confirm research-chemical import rules for the destination country before high-value orders.
Janoshik-listed lots in the COA library add a verification layer when third-party testing sits on your vendor scorecard.
Peer-reviewed papers should drive experimental design; supplier articles support procurement decisions only.
Freezer layouts that segregate peptides by project ID reduce cross-contamination risk in shared storage.
Research peptide supplied by Sulan Peptide Official is research-use only (RUO)—not for human or veterinary use, diagnosis, or treatment. For specification or quotation questions, use the Contact page or WhatsApp on sulan-peptide.shop.